Stock Events

Stock Events

HLS Therapeutics (HLTRF) Q2 2026 Earnings

15MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.14

-0.11

-0.09

-0.06

Details

Expected EPS

-0.12

Actual EPS

-0.07

Surprise EPS

0.05

Surprise Percent

+41.67%

Description

HLS Therapeutics (HLTRF) has reported earnings of -0.07 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.